Net profit of Fredun Pharmaceuticals rose 72.08% to Rs 4.13 crore in the quarter ended June 2024 as against Rs 2.40 crore during the previous quarter ended June 2023. Sales rose 26.64% to Rs 77.54 crore in the quarter ended June 2024 as against Rs 61.23 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 77.54 | 61.23 | 27 |
| OPM % | 13.52 | 12.43 | - |
| PBDT | 6.57 | 5.00 | 31 |
| PBT | 5.52 | 4.08 | 35 |
| NP | 4.13 | 2.40 | 72 |